Question special
Lead Moderator

This study also found that there were unacceptably high rates (80%) of MDR-TB treatment failure. With this in mind, how do we scale up a) universal access to rapid DST b) improved treatment across the entire cascade of care including adherence/nutritional support as well as access to high-quality effective drugs?